Although we only tested selective phospho‐tau residues (AD2, CP13, AT180, AT8), these represent the overall state of tau phosphorylation in PSP (Feany et al, 1995; Wray et al, 2008). The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.